Billionaire Leon Cooperman Says Investors Are Acting Like ‘Pavlov’s Dog’ — Reveals 2 New Stock Picks

Leon Cooperman expressed a negative market view due to rising fiscal deficit and debt, citing Warren Buffett's analogy of investors acting like 'Pavlov's dogs'. Omega Advisors, managed by Cooperman, revealed new positions in Amrize AG (AMRZ) and GPGI (GPGI). Amrize reported Q2 revenue growth but missed EBITDA expectations, with RBC downgrading the stock to underperform. Management expects pricing to align with costs by Q4.

Original reporting
Published Aug 24, 2026, 3:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 4:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Billionaire Leon Cooperman Says Investors Are Acting Like ‘Pavlov’s Dog’ — Reveals 2 New Stock Picks — source image
Decision brief

The 30-second read

$AMRZBullishLow
01

Why it matters

Fund purchases introduce new institutional demand but are modest relative to market size.

02

Market read

The story adds a small, new data point on institutional buying for AMRZ and GPGI.

03

What to watch

RBC downgrade and margin compression could offset fund support.

Relevance 4/10Novelty 3/10Timing: none

Background

Leon Cooperman comments on market sentiment; article shifts to Omega Advisors' Q2 fund holdings.

Company-level read

Ticker impact

$AMRZBullishMedium confidence
Context

Omega Advisors disclosed buying 880,000 shares of AMRZ in its Q2 filing.

Expected impact

Modest upside potential as institutional demand appears.

Evidence & confidence

New institutional ownership can signal confidence but size is modest.

$GPGIBullishMedium confidence
Context

Omega Advisors disclosed buying 11.38 million shares of GPGI in its Q2 filing.

Expected impact

Potential short-term rally on fresh demand.

Evidence & confidence

Significant share count indicates strong interest from a known investor.

Market effects

Highlights continued interest in building‑materials and diversified industrial sectors.

No immediate regional effect beyond U.S. equities.

Limited to investors tracking fund activity.

Counterpoint

Fund buying may be premature if margins continue to pressure AMRZ.

Key entities

  • Leon Cooperman

    Billionaire investor providing market commentary.

  • Omega Advisors

    Asset manager reporting new Q2 holdings.

Related articles

$AMRZHigh

Jefferies downgrades Amrize stock rating on margin concerns

Jefferies downgraded Amrize (NYSE:AMRZ) to Underperform, cutting its price target to $35.20 from $42.80. Analyst Glynis Johnson cited margin concerns due to rising costs and tough comparisons in 2027. The stock is down 23% year-to-date. Jefferies forecasts continued cost pressures will impact margins. Amrize reported Q3 2026 earnings beating profit estimates but missing revenue targets.

$BETAMed

5 Stocks Analysts Just Downgraded

Wall Street analysts downgraded five stocks: BETA Technologies (BETA), TransUnion (TRU), Molson Coors (TAP), Amrize (AMRZ), and another. Downgrades cited delivery delays, slower growth, soft demand, and cost pressures. BETA's Q3 revenue doubled, but deliveries were delayed. TransUnion's revenue rose 12.2%, but margins slipped. Molson Coors saw net sales fall 1.6% and lowered earnings guidance. Amrize adjusted EBITDA and revenue forecasts due to cost inflation.

$GPGIMed

GPGI 3Q 2026: Revenue $0, EPS $0.26 — 10-Q Summary

GPGI reported 3Q 2026 revenue of $0 but net income of $76M, up 143.5% YoY, driven by equity-method investment earnings. GPGI Holdings sales rose 321.5% YoY to $509.6M, with Husky and CompoSecure contributing to growth. Adjusted EBITDA for CompoSecure and Husky combined was $150.0M, up from $49.8M YoY.

$GPGIHighAI 8/10

GPGI (GPGI) Q3 2026 Earnings Call Transcript

GPGI reported Q3 2026 earnings with sales up 5% YoY to $509.6M and EBITDA up 7% to $146.3M. The company expects low single-digit revenue growth and high single-digit EBITDA growth in Q4. Full-year 2026 guidance was adjusted, with revenue expected to meet prior forecasts but EBITDA and free cash flow lowered due to Husky's delayed cost actions and mix issues. GPGI aims for long-term growth with mid- to high single-digit annual organic growth and double-digit EBITDA growth.

$GPGILow

GPGI Third Quarter 2026 Earnings Presentation November 5, 2026 TM

GPGI, Inc. (GPGI) filed an SEC Form 8-K — Results of Operations and Financial Condition. GPGI Third Quarter 2026 Earnings Presentation November 5, 2026 TM Disclaimer 2 Caution Concerning Forward-Looking Statements: This presentation, and other statements that GPGI, Inc. (“GPGI,” “we,” “us” or the “Company”) may make in connection therewith, contains forward-looking s